From therapeutic point of view, DNA demethylation of Rab37 and SFRP1 genes34,35, increased stability of Rab37 protein36 and activation of SFRP1 function32 are some potential ways to develop cancer therapy for lung cancer. This evidence concerns the gene RAB37 and lung carcinoma.